MorphoSys launches US IPO

MorphoSys AG has filed a registration statement with the US Securities and Exchange Commission to make an initial public offering of its shares on the Nasdaq market. The offering will consist of up to 8.3 million American Depositary Shares (ADSs), the German company said on 9 April.

Full text available to subscribers only. Click here for information on subscribing to MedNous.